Open AccessDiscontinuation of imatinib may be possible in chronic myelogenous leukemia
Author(s) -
Barton Mary Kay
Publication year - 2011
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.20110
Subject(s) - chronic myelogenous leukemia , discontinuation , imatinib , leukemia , medicine , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom